mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.008 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.009 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.01 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.01 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.01 |